Firefly Neuroscience vs MeMed

Firefly Neuroscience vs MeMed, compared side by side on 23 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Firefly Neuroscience is on 56/100 and MeMed on 61/100.

Firefly Neuroscience logo
Firefly NeuroscienceFirefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.
Try Firefly Neuroscience
MeMed logo
MeMedMeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.
Try MeMed

Where each one leads

Firefly Neuroscience

  • agent readiness: 49/100 against 35/100
  • headcount growth: -3.3% against -8.4%

MeMed

  • our overall score: 61/100 against 56/100
  • domain rating: 46/100 against 38/100
  • headcount: 99 against 25
  • funding raised: $196M against $45.4M
  • LinkedIn following: 21,207 against 8,237

At a glance

MeasureFirefly NeuroscienceMeMed
What it isFirefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.
CategoryHealthcare, Neurology, Mental Health, Brain EEG InjuryHealthcare, Blood, Diagnostics, MedTech
Sells toBusiness modelB2BB2B, B2G
OfferingSoftware, HardwareSoftware, Hardware
Founded20062009
HeadquartersSan Francisco, United StatesTirat Carmel, Israel
StatusActiveActive

Size, funding and growth

MeasureFirefly NeuroscienceMeMed
Employees2599
Headcount growthLast 12 months-3.3%-8.4%
Total funding$45.4M$196M
Latest roundSeries CSeries E
LinkedIn followers8,23721,207

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureFirefly NeuroscienceMeMed
StartupHub scoreOur 0-100 rating56/10061/100
Traction52/10060/100
Team50/10070/100
Community8/100Not published
Search visibility25/10029/100
Quality62/10065/100
Agent readinessHow well an AI agent can read and act on the siteD (49/100)F (35/100)
Domain ratingLink authority, 0-10038/10046/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureFirefly NeuroscienceMeMed
HostingAWSSelf Managed
CMSWordPressWordPress
FrameworksJqueryJquery
AnalyticsGoogle Analytics 4, Google Tag ManagerGoogle Analytics 4, Google Tag Manager
Support stackHubSpotNot detected

Firefly Neuroscience vs MeMed: common questions

Which is better, Firefly Neuroscience or MeMed?

On our 0-100 score MeMed rates higher (61/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 23 data points above: read the rows that match what you are buying for.

How do Firefly Neuroscience and MeMed compare on the numbers?

Firefly Neuroscience leads on agent readiness (49/100 against 35/100), headcount growth (-3.3% against -8.4%). MeMed leads on our overall score (61/100 against 56/100), domain rating (46/100 against 38/100), headcount (99 against 25), funding raised ($196M against $45.4M), LinkedIn following (21,207 against 8,237).

Read the full Firefly Neuroscience review and pricing or the MeMed review and pricing. You can also browse other Firefly Neuroscience alternatives we track.